Subscriber Login

•  
•  Home 
• About Us &
  Subscriptions
• Editorial
  Board
• Contents
• Instructions
  to Authors
• Submit
  a Manuscript
• External
  Links

Advertisement:

You are here: Contents > 2012 > Volume 21 Number 5 September 2012 > THROMBOSIS, EMBOLISM AND BLEEDING

THROMBOSIS, EMBOLISM AND BLEEDING

The Combined Effects of Clinical Factors and CYP2C9 and VKORC1 Gene Polymorphisms on Initiating Warfarin Treatment in Patients after Cardiac Valve Surgery Vacis Tatarūnas, Vaiva Lesauskaitė, Audronė Veikutienė, Pranas Grybauskas, Povilas Jakuška, Rimantas Benetis	628
Management of Heparin-Induced Thrombocytopenia during Thrombolytic Therapy for Prosthetic Valve Thrombosis Mehmet Özkan, Ali E. Oğuz, Ozan M. Gürsoy, Sabahattin Gündüz, Çağrı A. Aykan, Mehmet A. Astarcıoğlu, Mustafa Yıldız	636

 

 

Select From:

• 2018-19
• 2017
• 2016
• 2015
• 2014
• 2013
• 2012
• Volume 21 Number 6 November 2012
• Volume 21 Number 5 September 2012
• MITRAL VALVE DISEASE
• AORTIC VALVE DISEASE
• THROMBOSIS, EMBOLISM AND BLEEDING
• The Combined Effects of Clinical Factors and CYP2C9 and VKORC1 Gene Polymorphisms on Initiating Warfarin Treatment in Patients after Cardiac Valve Surgery
• Management of Heparin-Induced Thrombocytopenia during Thrombolytic Therapy for Prosthetic Valve Thrombosis
• TRIPLE VALVE SURGERY
• REPLACEMENT DEVICES
• CASE REPORTS
• LETTER TO THE EDITOR
• IMAGES OF THE MONTH
• Volume 21 Number 4 July 2012
• Volume 21 Number 3 May 2012
• Volume 21 Number 2 March 2012
• Volume 21 Number 1 January 2012
• 2011
• 2010
• 2009
• 2008
• 2007
• 2006
• 2005
• 2004
• 2003
• 2002
• 2001
• 2000
• 1999
•  

Search:

Search Whole Site Published Articles Only Published Abstracts Only

© ICR Publishers Ltd 2021. All rights reserved.
Website by CHP Design, London